| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.36 | 0.04 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.35 | 0.04 |